4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide

C31H42N2O4S — CID 126714193

IUPAC4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide
SMILESCc1cnc(NC(=O)CCCC2C[C@H](O)[C@@]3(C)CCC4c5ccc(OC6CCCCO6)cc5CCC4C23)s1
InChIInChI=1S/C31H42N2O4S/c1-19-18-32-30(38-19)33-27(35)7-5-6-21-17-26(34)31(2)14-13-24-23-12-10-22(37-28-8-3-4-15-36-28)16-20(23)9-11-25(24)29(21)31/h10,12,16,18,21,24-26,28-29,34H,3-9,11,13-15,17H2,1-2H3,(H,32,33,35)/t21?,24?,25?,26-,28?,29?,31+/m0/s1
InChIKeyRKOMCEUDTGEJFB-PRAQHSCGSA-N
MW538.75 g/mol
LogP6.61
Rot. Bonds7

About 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide

4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide (PubChem CID 126714193) has the molecular formula C31H42N2O4S and a molecular weight of 538.75 g/mol. Its IUPAC name is 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide.

Molecular Properties

Compound Name4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide
PubChem CID126714193
Molecular FormulaC31H42N2O4S
Molecular Weight538.75 g/mol
Exact Mass538.29
IUPAC Name4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide
SMILESCc1cnc(NC(=O)CCCC2C[C@H](O)[C@@]3(C)CCC4c5ccc(OC6CCCCO6)cc5CCC4C23)s1
InChIInChI=1S/C31H42N2O4S/c1-19-18-32-30(38-19)33-27(35)7-5-6-21-17-26(34)31(2)14-13-24-23-12-10-22(37-28-8-3-4-15-36-28)16-20(23)9-11-25(24)29(21)31/h10,12,16,18,21,24-26,28-29,34H,3-9,11,13-15,17H2,1-2H3,(H,32,33,35)/t21?,24?,25?,26-,28?,29?,31+/m0/s1
InChIKeyRKOMCEUDTGEJFB-PRAQHSCGSA-N
XLogP6.61
TPSA80.68 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500538.75
LogP ≤ 56.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide?
The IUPAC name of 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide (CID 126714193) is 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide.
What is the SMILES notation for 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide?
The canonical SMILES for 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide is Cc1cnc(NC(=O)CCCC2C[C@H](O)[C@@]3(C)CCC4c5ccc(OC6CCCCO6)cc5CCC4C23)s1.
What is the InChIKey of 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide?
The InChIKey is RKOMCEUDTGEJFB-PRAQHSCGSA-N. The full InChI is InChI=1S/C31H42N2O4S/c1-19-18-32-30(38-19)33-27(35)7-5-6-21-17-26(34)31(2)14-13-24-23-12-10-22(37-28-8-3-4-15-36-28)16-20(23)9-11-25(24)29(21)31/h10,12,16,18,21,24-26,28-29,34H,3-9,11,13-15,17H2,1-2H3,(H,32,33,35)/t21?,24?,25?,26-,28?,29?,31+/m0/s1.
What are the key properties of 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide?
4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide has a molecular weight of 538.75 g/mol, XLogP of 6.61, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(13S,15R,17S)-17-hydroxy-13-methyl-3-(oxan-2-yloxy)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-15-yl]-N-(5-methyl-1,3-thiazol-2-yl)butanamide is sourced from PubChem (CID 126714193), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).